BWA
BorgWarner Inc.
BWA has the edge over LCID overall, supported by lower modeled downside and stronger modeled upside.
LCID
Lucid Group, Inc.
LCID offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
BWA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Healthy |
BWA's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BWA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.1x | $50.99 | — |
| Cheap | 11x | $25.48 | -50% |
| Fair | 13x | $31.93 | -37% |
| Current | 21x | $50.99 | — |
| Expensive | 30x | $71.22 | +40% |
Historical ranges are pointers, not guarantees.
BWA's PE is in its expensive range at 21x. If earnings grow as analysts expect, today's price would be 9.1x next year's earnings, in its cheap range.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
BWA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect BWA's earnings to grow and its profitability to improve, with its revenue holding steady.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BWA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.60 | +135% |
| Q3 2026 | $2.38 | +240% |
| Q2 2026 | $2.03 | +101% |
| Q1 2026 | $1.72 | +30% |
| Q4 2025 | $1.28 | -15% |
| Q3 2025 | $0.70 | -82% |
| Q2 2025 | $1.01 | -68% |
| Q1 2025 | $1.32 | -50% |
| Q4 2024 | $1.50 | -44% |
BWA has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
BWA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.5B | -2.9% |
| Q2 2026 | $3.6B | +0.3% |
| Q1 2026 | $3.5B | +0.5% |
| Q4 2025 | $3.6B | +3.9% |
| Q3 2025 | $3.6B | +4.1% |
| Q2 2025 | $3.6B | +1% |
| Q1 2025 | $3.5B | -2.2% |
| Q4 2024 | $3.4B | -2.4% |
BWA's revenue fell from its 2023 peak and has held roughly level since: $3.5B last quarter, down 2.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.7% | +1.8 points |
| Q2 2026 | 10% | +2.2 points |
| Q1 2026 | 9.5% | +2.8 points |
| Q4 2025 | -6.7% | +2.5 points |
| Q3 2025 | 6.9% | -0.9 points |
| Q2 2025 | 7.9% | -0.3 points |
| Q1 2025 | 6.7% | -1.5 points |
| Q4 2024 | -9.2% | -17 points |
BWA has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over BWA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
BWA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $195M | -24% |
| Q2 2026 | $490M | -2.4% |
| Q1 2026 | $9M | +$46M |
| Q4 2025 | $457M | -12% |
| Q3 2025 | $257M | +28% |
| Q2 2025 | $502M | +69% |
| Q1 2025 | -$37M | +$271M |
| Q4 2024 | $521M | -23% |
BWA has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
BWA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -1.7M shares |
| 1 year | -5.5% | -11.9M shares |
| 3 years | -13% | -30.7M shares |
| 5 years | -15% | -35.2M shares |
| Available history | -1.1% | -2.2M shares |
BWA has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $175M |
| Q2 2026 | $100M |
| Q1 2026 | $150M |
| Q4 2025 | $298M |
| Q3 2025 | $102M |
| Q2 2025 | $108M |
| Q1 2025 | — |
| Q4 2024 | $1M |
BWA spent $723M buying back its own shares over the past year, about three times what it spent the year before.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
BWA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.0x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q4 2024 | 1.7x | Healthy |
| Q3 2024 | 1.4x | Healthy |
| Q2 2024 | 1.4x | Healthy |
| Q1 2024 | 1.5x | Healthy |
| Q4 2023 | 1.2x | Healthy |
| Q3 2023 | 1.4x | Healthy |
BWA's net debt is about a year of its operating earnings (EBITDA), down from 1.4 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BWA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.2 | Neutral |
| Stochastic | 8.4 | Oversold |
BWA's weekly RSI is 36 (neutral) and its Stochastic is 8 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BWA PE vs Consumer Cyclical Sector
| Metric | BWA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 71 | 47 | 24 pts above |
BWA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
BWA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.0 | 8.9% below |
| 20 week MA | $61.7 | 17% below |
| 50 week MA | $58.3 | 13% below |
| 100 week MA | $46.8 | 8.9% above |
| 200 week MA | $41.9 | 22% above |
BWA has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
BWA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $38.5 | $34.3 | -11% |
| 2021 | $34.3 | $38.4 | +12% |
| 2022 | $38.4 | $35.2 | -8.3% |
| 2023 | $35.2 | $35.9 | +1.9% |
| 2024 | $35.9 | $32.2 | -10% |
| 2025 | $32.2 | $45.6 | +42% |
| 2026 YTD | $45.6 | $51.0 | +12% |
BWA has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.